SMTL ID : 7q4q.1

Magacizumab Fab fragment in complex with human LRG1 epitope

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

hetero-2-2-2-mer

Ligands

2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)

TRS.1: 8 residues within 4Å: Chain B: E.153, P.154, V.155, T.170, F.171, P.172, A.173, L.183 7 PLIP interactions: 7 interactions with chain B Hydrogen bonds: B:E.153, B:V.155, B:V.155, B:T.170, B:A.173 Water bridges: B:E.153, B:V.155 TRS.2: 9 residues within 4Å: Chain D: Y.150, E.153, P.154, V.155, T.170, F.171, P.172, A.173, L.183 4 PLIP interactions: 4 interactions with chain D Hydrogen bonds: D:V.155, D:T.170, D:A.173 Water bridges: D:A.173

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gutierrez-Fernandez, J. et al., Structural basis of human LRG1 recognition by Magacizumab, a humanized monoclonal antibody with therapeutic potential. Acta Crystallogr D Struct Biol (2022)

Release Date

2022-06-15

Peptides

Magacizumab light chain: AC
Magacizumab heavy chain: BD
LRG1 epitope: EF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

E
E

F
F

Magacizumab light chain

Magacizumab heavy chain

LRG1 epitope